Glenmede Trust’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-30,559
| Closed | -$422K | – | 1300 |
|
|
2021
Q2 | $422K | Buy |
+30,559
| New | +$422K | ﹤0.01% | 928 |
|
|
2020
Q4 | – | Sell |
-928
| Closed | -$17K | – | 1395 |
|
|
2020
Q3 | $17K | Buy |
928
+345
| +59% | +$6.32K | ﹤0.01% | 1669 |
|
|
2020
Q2 | $10K | Buy |
583
+552
| +1,781% | +$9.47K | ﹤0.01% | 1853 |
|
|
2020
Q1 | $0 | Hold |
31
| – | – | ﹤0.01% | 3015 |
|
|
2019
Q4 | $0 | Hold |
31
| – | – | ﹤0.01% | 3024 |
|
|
2019
Q3 | $0 | Hold |
31
| – | – | ﹤0.01% | 3023 |
|
|
2019
Q2 | $0 | Hold |
31
| – | – | ﹤0.01% | 3078 |
|
|
2019
Q1 | $0 | Hold |
31
| – | – | ﹤0.01% | 3069 |
|
|
2018
Q4 | $0 | Buy |
+31
| New | – | ﹤0.01% | 3024 |
|
|
2016
Q4 | – | Sell |
-31
| Closed | – | – | 2483 |
|
|
2016
Q3 | $0 | Buy |
+31
| New | – | ﹤0.01% | 2587 |
|